Navigation Links
New discovery paves the way for new diagnosis of serious lung disease
Date:3/2/2009

The discovery by Uppsala University researchers of a previously unknown protein in the cells of the lower air ways brings new potential for early diagnosis of a serious lung disease. The findings, published today in the Web edition of the American journal Proceedings of the National Academy of Sciences, can also provide new knowledge of the cause of common diseases like asthma and chronic bronchitis.

Researchers at Uppsala University and Uppsala University Hospital have identified a protein in the lungs that is important to the immune defense system in an autoimmune lung disorder that is not seldom fatal. The newly discovered protein, called KCNRG, occurs in cells in the lower air ways found on the surface of the bronchia. This observation enables researchers to study more closely the first phase of the autoimmune disease, that is, when the immune system erroneously attacks the body's own tissues instead of attacking foreign organisms like bacteria or viruses. The discovery also provides new avenues for developing new diagnostic methods.

The researchers used an unusual hereditary autoimmune disorder, autoimmune polyendocrine syndrome type 1 (APS-1), as a model. Patients with this disease are afflicted by the immune system erroneously attacking several tissues, such as the liver, insulin-producing cells, and adrenal glands.

"Only now have we understood that the lungs are attacked as well and that in many cases this is the most serious component of the disease APS-1," says Dr. Mohammad Alimohammadi.

"It's our hope that the discovery of the protein that the immune system targets, besides making early diagnosis possible, will also be possible to use in understanding the mechanism behind the occurrence of common public health disorders like asthma and chronic bronchitis."


'/>"/>

Contact: Mohammad Alimohammadi
mohammad.alimohammadi@medsci.uu.se
46-070-882-9922
Uppsala University
Source:Eurekalert

Page: 1

Related biology news :

1. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
2. Rett Syndrome Research Trust advisor makes significant discovery
3. Singapore research organisations team up to advance drug discovery using brain tumor stem cells
4. Breaking the barrier: Discovery of anti-resistance factors and novel ocean drugs
5. Major step for drug discovery and diagnostics
6. Cell-building discovery could reduce need for some animal research
7. New discovery may lead to new class of allergy drugs
8. Discovery could lead to a new animal model for hepatitis C
9. Billion-year revision of plant evolution timeline may stem from discovery of lignin in seaweed
10. Cancer-causing gene discovery suggests new therapies
11. Jumbo-sized discovery made in Malaysia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
Breaking Biology News(10 mins):
(Date:8/10/2017)... Indiana (PRWEB) , ... August 09, 2017 , ... ... equipped to help the agriculture industry reach its ideal customers with the right ... the nation. , “As a Midwest company, we realize how crucial the agriculture ...
(Date:8/10/2017)... ... , ... Each year in the United States more than 300,000 people are ... lifestyle and, even worse, the one-year mortality rate is high, ranging from 12 percent ... California Davis Medical Center (Sacramento) and Second Xiangya Hospital of the Central-South University (Hunan, ...
(Date:8/10/2017)... ... August 10, 2017 , ... DrugDev and the Society ... to demonstrate how Good Clinical Practice (GCP) can be used throughout the site activation ... will discuss the importance of GCP compliance, how sites are affected by GCP during ...
(Date:8/10/2017)... ... August 10, 2017 , ... BellBrook Labs announces ... Assay , an enabling new high throughput screening (HTS) assay to aid researchers ... other debilitating diseases. , Chemical modification of gene expression, also known as epigenetics, ...
Breaking Biology Technology: